$B9V1i(B $B;~9o(B | $B9V1i(B $BHV9f(B | $B9V1iBjL\!?H/I= | $B%-!<%o!<%I(B | $BJ,N`(B $BHV9f(B | $B |
---|---|---|---|---|---|
$B:`NA!&3&LL(B | |||||
(9:20$B!A(B10:00)$B!!(B($B:BD9(B $BBl;3!!Gn;V(B) | |||||
G102 | L-$B%0%k%?%_%s;@7k>=B?7A$X$N%"%_%N;@E:2CJ*$N:.F~$H%b%k%U%)%m%8! | L-glutamic acid additive morphology | 12-g | 112 | |
G103 | BPT-est$BB?7A$N@O=P5sF0$HE>0\B.EY$N4X78$J$i$S$KMOG^8z2L(B | Polymorphism transformation kinetics solvent effect | 12-g | 113 | |
(10:00$B!A(B11:00)$B!!(B($B:BD9(B $BKLB | |||||
G104 | $BE:2CJ*B8:_2<$G$N%"%;%H%"%_%N%U%'%s7k>=$NB?7AE>0\8=>]$N2r@O(B | crystallization polymorphism transformation | 12-g | 392 | |
G105 | $BL55!%j%s2=9gJ*$N@=IJ7k>=IJ=@.D98=>](B | crystallization crystal quality impurity | 12-g | 236 | |
G106 | $B | crystallization crystal size distribution purity | 12-g | 332 | |
(11:00$B!A(B12:00)$B!!(B($B:BD9(B $BD+7'(B $BM52p(B) | |||||
G107 | NaCl$B!"(BKCl$B!"(BNaBr$B!"(BKBr$B$r4^$`7O$N8GAj7k>=2=$K5Z$\$9%a%+%N%1%_%+%k8z2L(B | Solid state crystallization mechano-chemical effect metal halides | 12-g | 654 | |
G108 | $B%a%+%N%1%_%+%kK!$K$h$kM-5!7k>=B?7A$NH/8=$H@)8f(B | mechano-chemical processing polymorphic transformation additive | 12-g | 661 | |
G109 | $B%a%+%N%1%_%+%kK!$K$h$k%"%_%N;@$N8GMOBN$N7A@.(B | mechano-chemical processing amino acid solid solution | 12-g | 663 | |
$BCk5Y$_(B | |||||
(13:00$B!A(B14:00)$B!!(B($B:BD9(B $BCSED!!0l;K(B) | |||||
G113 | Theophylline$B$N8GAjB?7AE>0\$K$*$1$k<>EY$N1F6A(B | Polymorphic transition Humidity Theophylline | 12-g | 656 | |
G114 | $BH?1~>=@O$K$h$k?e;@2=%K%C%1%k7k>=$N@8@.>r7o$H7k>=;R%5%$%:$*$h$SN37B$N4X78(B | precipitation crystallite size particle size | 12-g | 657 | |
G115 | $B%K%3%A%s%"%_%I(B-$B%5%j%A%k;@(Bcocrystal$B$N7A@.(B | cocrystal Nicotinamide Salicylic acid | 12-g | 664 | |
(14:00$B!A(B15:00)$B!!(B($B:BD9(B $BA0ED!!8w<#(B) | |||||
G116 | $BH?1~>=@OK!$rMQ$$$?=jK>$NJ*@-$r;}$D7V8w@-%/%m%m%"%Q%?%$%H$NAO@=$K4X$9$k8!F$(B | precipitation apatite fluorescence substance | 12-g | 102 | |
G117 | $B0eLtIJ86Lt$NNd5Q>=@O$K5Z$\$9%9%1!<%k%"%C%WMW0x$N1F6A(B | crystallization scale up particle size distribution | 12-g | 11 | |
G118 | $B9bJ,;REE2r=@OAO@=(B | reductive crystallization nanoparticle polyelectrolyte | 12-g | 203 | |
(15:00$B!A(B16:00)$B!!(B($B:BD9(B $B=BC+(B $BGn8w(B) | |||||
G119 | $B1v2=%J%H%j%&%`>=@OAuCVFb$K$*$1$kHy7k>=7|ByN($N@)8f$K4X$9$k8!F$(B | Crystallization Fine crystal Sodium chloride | 12-g | 244 | |
G120 | $B1v4p@-$N5$(B-$B1U3&LLH?1~>l$rMQ$$$?C:;@%+%k%7%&%`$NH?1~>=@O(B | micro bubble calcium carbonate polymorphism | 12-g | 713 | |
G121 | $BM-5!2=9gJ*(BBPPI$B$NMOG^OBJ*@O=P$N%a%+%K%:%`(B | Solvate crystal Solvent composition NMR | 12-g | 480 | |
(16:00$B!A(B16:40)$B!!(B($B:BD9(B $B8^==Mr!!9,0l(B) | |||||
G122 | $B%7!<%IE:2CB?CJNd5Q%P%C%A>=@O$N%7%_%e%l!<%7%g%s!>7k>=N3EY$KBP$9$k(B2$B(B | Batch crystallization crystal size distribution simulation | 12-g | 84 | |
G123 | $BIOMOG^>=@O$NJ,;RF0NO3XK!(B | Molecular Dynamics Anti-solvent Crystallization | 12-g | 389 |